Vesicular activators of the NF-κB-signaling pathway (e.g., TNF-α and TGF-β) secreted by prostate cancer cells trigger the differentiation of fibroblasts into CAFs, promote stemness, and angiogesis (31, 32). Here, TNF is linked to prostate carcinoma.